Jentashapir Journal of Health Research

Published by: Kowsar

Assessment of Serum Tri-Iodothyronine (T3), Thyroxin (T4) and Thyroid-Stimulating Hormone (TSH) Levels Among Patients With Major Depressive Disorder (MDD) in Hamedan, Northwestern Iran

Seyed Mehrdad Kassaee 1 , * , Rahim Ahmadi 1 , Asghar Seif 2 and Sedigheh Molaei 3
Authors Information
1 Department of Physiology, Faculty of Basic Sciences, Hamedan Branch, Islamic Azad University, Hamedan, IR Iran
2 Department of Statistics, Faculty of Basic Sciences, Bu-Ali Sina University, Hamedan, IR Iran
3 School of Medicine, Student Research Committee, Qom University of Medical Sciences, Qom, IR Iran
Article information
  • Jentashapir Journal of Health Research: April 01, 2016, 7 (2); e23066
  • Published Online: April 27, 2016
  • Article Type: Research Article
  • Received: August 26, 2014
  • Revised: November 26, 2015
  • Accepted: December 2, 2015
  • DOI: 10.17795/jjhr-23066

To Cite: Kassaee S M, Ahmadi R, Seif A, Molaei S. Assessment of Serum Tri-Iodothyronine (T3), Thyroxin (T4) and Thyroid-Stimulating Hormone (TSH) Levels Among Patients With Major Depressive Disorder (MDD) in Hamedan, Northwestern Iran, Jentashapir J Health Res. 2016 ; 7(2):e23066. doi: 10.17795/jjhr-23066.

Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Lucas M, Mirzaei F, Pan A, Okereke OI, Willett WC, O'Reilly EJ, et al. Coffee, caffeine, and risk of depression among women. Arch Intern Med. 2011; 171(17): 1571-8[DOI][PubMed]
  • 2. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. The Lancet. 2013; 382(9904): 1575-86
  • 3. Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Lee D, et al. Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder. J Affect Disord. 2014; 169: 112-7[DOI][PubMed]
  • 4. Fjaellegaard K, Kvetny J, Allerup PN, Bech P, Ellervik C. Well-being and depression in individuals with subclinical hypothyroidism and thyroid autoimmunity - a general population study. Nord J Psychiatry. 2015; 69(1): 73-8[DOI][PubMed]
  • 5. Kim EY, Kim SH, Rhee SJ, Huh I, Ha K, Kim J, et al. Relationship between thyroid-stimulating hormone levels and risk of depression among the general population with normal free T4 levels. Psychoneuroendocrinology. 2015; 58: 114-9[DOI][PubMed]
  • 6. Roberts RE, Shema SJ, Kaplan GA, Strawbridge WJ. Sleep complaints and depression in an aging cohort: A prospective perspective. Am J Psychiatry. 2000; 157(1): 81-8[DOI][PubMed]
  • 7. Jackson IM. Does thyroid hormone have a role as adjunctive therapy in depression? Thyroid. 1996; 6(1): 63-7[DOI][PubMed]
  • 8. Dayan CM, Panicker V. Hypothyroidism and depression. Eur Thyroid J. 2013; 2(3): 168-79[DOI][PubMed]
  • 9. Veldhoen N, Propper CR, Helbing CC. Enabling comparative gene expression studies of thyroid hormone action through the development of a flexible real-time quantitative PCR assay for use across multiple anuran indicator and sentinel species. Aquat Toxicol. 2014; 148: 162-73[DOI][PubMed]
  • 10. Shakeri J, Jaberghaderi N, Rezaei M, Saeedi M, Naleini M, Moloodi A. Psychosocial risk factors in patients with cardio-vascular diseases in Kermanshah (2006) Psychosocial risk factors in patients with cardio-vascular diseases in Kermanshah (2006) Psychosocial risk factors in patients with cardio-vascular diseases in Kermansh. J Kermanshah Univ Med Sci. 2012; 16(3): 246-54
  • 11. Pahlavanzadeh S, Navidian A, Yazdani M. The effect of psycho-education on depression, anxiety and stress in family caregivers of patients with mental disorders. Journal of Kermanshah University of Medical Sciences (J Kermanshah Univ Med Sci). 2010; 14(3)
  • 12. Lolis MS, Goldberg DJ. Clinical Dermatology Trials 101. 2015; : 135-42
  • 13. Farinde A. The Beck Depression Inventory. The Pharma Innovation-Journal. 2013; 2(1): 56-62
  • 14. Pakseresht S, Boustani H, Azemi ME, Nilsaz J, Babapour R, Haghdust MR. Evaluation of Pharmaceutical Products of St. John's Wort Efficacy Added on Tricyclic Antidepressants in treating Major Depressive Disorder: A Double Blind Randomized Control Trial. Jundishapur J Nat Pharm Prod. 2012; 7(3): 106-10[PubMed]
  • 15. Hayden MJ, Brown WA, Brennan L, O'Brien PE. Validity of the Beck Depression Inventory as a screening tool for a clinical mood disorder in bariatric surgery candidates. Obes Surg. 2012; 22(11): 1666-75[DOI][PubMed]
  • 16. Ghasemi A, Zahediasl S. Normality tests for statistical analysis: a guide for non-statisticians. Int J Endocrinol Metab. 2012; 10(2): 486-9[DOI][PubMed]
  • 17. Das BK, Baral N, Shyangwa PM, Toora BD, Lamsal M. Altered serum levels of thyroxine, triiodothyroinine and thyroid stimulating hormone in patients with depression. KUMJ. 2006; 5(3): 330-4
  • 18. Gold MS, Pottash AC, Mueller E3, Extein I. Grades of thyroid failure in 100 depressed and anergic psychiatric inpatients. Am J Psychiatry. 1981; 138(2): 253-5[DOI][PubMed]
  • 19. Fountoulakis KN, Iacovides A, Grammaticos P, St Kaprinis G, Bech P. Thyroid function in clinical subtypes of major depression: an exploratory study. BMC Psychiatry. 2004; 4: 6[DOI][PubMed]
  • 20. Wu EL, Chien IC, Lin CH, Chou YJ, Chou P. Increased risk of hypothyroidism and hyperthyroidism in patients with major depressive disorder: a population-based study. J Psychosom Res. 2013; 74(3): 233-7[DOI][PubMed]
  • 21. Najafi L, Malek M, Hadian A, Ebrahim Valojerdi A, Khamseh ME, Aghili R. Depressive symptoms in patients with subclinical hypothyroidism-the effect of treatment with levothyroxine: a double-blind randomized clinical trial. Endocr Res. 2015; 7(4): 1-6
  • 22. Biondi B, Wartofsky L. Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? J Clin Endocrinol Metab. 2012; 97(7): 2256-71[DOI][PubMed]
  • 23. van de Ven AC, Muntjewerff JW, Netea-Maier RT, de Vegt F, Ross HA, Sweep FC, et al. Association between thyroid function, thyroid autoimmunity, and state and trait factors of depression. Acta Psychiatr Scand. 2012; 126(5): 377-84[DOI][PubMed]
  • 24. Budania S, Rathi M, Singh S, Yadav S, Verma N. Depression and thyroid function tests. Muller. 2015; 6(1): 54-62
  • 25. Joffe RT, Pearce EN, Hennessey JV, Ryan JJ, Stern RA. Subclinical hypothyroidism, mood, and cognition in older adults: a review. Int J Geriatr Psychiatry. 2013; 28(2): 111-8[DOI][PubMed]
  • 26. Demartini B, Masu A, Scarone S, Pontiroli AE, Gambini O. Prevalence of depression in patients affected by subclinical hypothyroidism. Panminerva Med. 2010; 52(4): 277-82[PubMed]
  • 27. Howland RH. Use of endocrine hormones for treating depression. J Psychosoc Nurs Ment Health Serv. 2010; 48(12): 13-6[DOI][PubMed]
  • 28. Premachandra BN, Kabir MA, Williams IK. Low T3 syndrome in psychiatric depression. J Endocrinol Invest. 2006; 29(6): 568-72[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments